prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Her2, Path No.: Date Obtained: (Age: ). Date Received: F. See Addendum/Procedure. SPECIMEN: A:Lymph node, right axilla sentinel node, biopsy. B:Breast, right, lumpectomy. C:Lymph nodes, right axilla, dissection. DIAGNOSIS(ES): A. Lymph node, right axilla sentinel node, biopsy: - Carcinoma in 1 sentinel node following carcinoma of right breast. B. Breast, right, lumpectomy: - Carcinoma, invasive ductal type, moderately-differentiated, with focal micropapillary features,. Nottingham's score 5 (2+2+1). - Carcinoma, intraductal, comedo type with microcalcifications. - Lobular neoplasia, focal, classical type. - Fibrocystic disease, proliferative, with apocrine metaplasia, sclerosing adenosis and. microcalcifications. - Cicatricial fibrosis and organizing granulation tissue with fat necrosis, consistent with previous. biopsy site. - Fibroadenoma, microscopic. C. Lymph nodes, right axilla, dissection: - No evidence of carcinoma in 14 lymph nodes. Date Dictated: CLINICAL INFORMATION: Breast cancer. GROSS DESCRIPTION: The specimen is received in three parts. Part A is received fresh from the operating room for frozen section diagnosis in a container labeled with the patient's. name and "R sentinel lymph node". It consists of one firm tan to red lymph node measuring 2.0 x 1.8 X 1,0 cm, The. specimen is serially sectioned. Submitted in toto in three cassettes labeled AFS, A1 and A2. AFS = frozen section, A1. - A2 = remaining tissue,. Part B is received unfixed in a container labeled with the patient's name and "R breast lumpectomy". It consists of a. piece of yellow-white fibrofatty tissue measuring 10.5 X 9.0 x 6,0 cm. An ellipse of skin is not present. An X-ray is. received. A localization needle is not noted. A short suture is noted indicating the superior margin and a row of long. sutures are noted indicating the lateral margin. A mass is palpated in the center. The superficial surface is inked yellow. and the deep surface is inked black. The specimen is serially sectioned. On cut section, the mass is tan, firm, poorly. circumscribed and measures 3.2 x 3.0 x 3.0 cm. The mass comes to 0.3 cm of the superficial, 0.5 cm of the deep and. 2.5 cm of the lateral margins. The tissue is composed of 60% fat and 40% intermixed firm tan-white parenchyma. Representative sections are submitted in 29 cassettes labeled B1 - B29. Legend: B1 = mass and closest deep surface,. B2 = mass and closest superficial surface(B1 and B2 = full thickness of mass),. B3 - B8 = mass with adjacent deep margin. B9 - B17 = superficial margin over mass. B18 - B19 = mass. B20 - B21 = superior. B22 - B23 = deep margin in lateral part(closest to mass). B24 - B25 If lateral. B26 - B27 = inferior. B28 - B29 = medial. Part C is received unfixed in a container labeled with the patient's name and "R axillary lymph node dissection". It. consists of two pieces of yellow-red fatty tissue measuring 4.0 x 2.7 x 1.0 cm and 10.0 x 7.0 X 1.0 cm. A suture is noted. attached to one end of the larger piece of fatty tissue. Fourteen lymph moves measuring from 0.6 X 0.5 x 0.5 cm. to. 3.5. x 1.5 x 1.0 cm are identified. The lymph nodes are submitted in toto 10 cassettes labeled C1 - C10. Legend: C1 = five intact nodes, C2 - C5 = one bisected node in each cassettes, C6 = one intact node, C7 - C8 = one. large quadrisected node, C9 - C10 = nodes closest to suture(larger node is bisected). INTRAOPERATIVE CONSULTATION: AFS: Metastatic carcinoma in lymph node. Performed by: Resident: interpreted by: Attending: MICROSCOPIC DESCRIPTION: I. TYPE OF SPECIMEN: Right breast, excisional biopsy/lumpectomy. Right axillary node dissection. II. LOCATION OF THE TUMOR: Upper outer quadrant. III. TYPE OF NEOPLASM: Carcinoma, invasive - ductal type NOS with micropapillary features. Histological Grading: Moderately differentiated. (Nuclear grade 2 and Tubular & Glandular differentiation grade 2). Ductal carcinoma in situ, nuclear grade 3, multifocal 10%. intraductal comedo subtype. Necrosis is present within the intraductal subtype. Lobular neoplasia, type A (monomorphic), Focal in 2 of 29 slides. IV. GROSS/MICRO FINAL INVASIVE TUMOR SIZE INTERPRETATION: 3.2 x 3.0 x 3.0 cm. V. BORDERS OF INVASIVE NEOPLASM: III-defined. VI. VASCULAR SPACE INVASION: Present in lymphatics. VII. CALCIFICATION: Present in both malignant and benign areas. VIII. NIPPLE: N/A. IX. SKIN: N/A. X. ADJACENT BREAST TISSUE: Fibroadenoma (size 0,2 cm.). Cystic disease, proliferative. XI. SURGICAL MARGIN: No carcinoma is identified on surgical margins. Tumor distance from closest deep (slide "B1") margin: 0.6 cm. XII. AXILLARY LYMPH NODES: TOTAL: 15. HIGH POINT: 2. SENTINEL NODE: 1. XIII. POSITIVE LYMPH NODES: TOTAL: 1. HIGH POINT: 0. SENTINEL NODE: 1. DEGREE OF INVOLVEMENT: Extensive replacement. EXTRANODAL EXTENSION: Present. XIV. PECTORAL MUSCLE: No pectoral muscle identified. This report has been reviewed electronically and signed on. Interpreted by: Attending: The diagnosis was rendered by the attending pathologist. Addendum. ADDENDUM. Slides were reviewed by. The diagnosis rendered is in. agreement with the original diagnosis. This procedure/addenda has been electronically reviewed and signed on. Interpreted by: Attending: Note: Immunochemistry testing performed at. was developed and Its performance characteristics determined by the. These tests were interpreted in conjunction with external positive and internal negative controla, unless otherwise noted It has not been cleared or approved by the US. FDA. This test is used for clinical purposes only, It should not be regarded as Investigational or for research.

expanded version (tokens=1957) : 
 Histological Classification:
- Carcinoma in 1 sentinel node following carcinoma of right breast.
- Invasive ductal carcinoma, moderately-differentiated, with focal micropapillary features, Nottingham's score 5 (2+2+1).
- Intraductal carcinoma, comedo type with microcalcifications.
- Lobular neoplasia, type A (monomorphic), focal in 2 of 29 slides.
- Fibroadenoma, microscopic.
- Cicatricial fibrosis and organizing granulation tissue with fat necrosis, consistent with previous biopsy site.
- Fibrocystic disease, proliferative, with apocrine metaplasia, sclerosing adenosis and microcalcifications.

Subtype: Her2

Necrosis: Necrosis is present within the intraductal subtype.

Tumor infiltrating lymphocytes: Not mentioned.

Histological grade: Moderately differentiated. (Nuclear grade 2 and Tubular & Glandular differentiation grade 2) 

Nuclear grade: Invasive ductal carcinoma, moderately-differentiated. Nuclear grade 2.

Lymphovascular invasion: Present in lymphatics.

Calcification: Present in both malignant and benign areas.

Receptor status: HER2 subtype mentioned.

Ancillary testing results: Immunochemistry testing performed at. was developed and its performance characteristics determined by the. These tests were interpreted in conjunction with external positive and internal negative controls, unless otherwise noted. It has

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2110) : 
 Report: The patient has Her2 subtype breast cancer with invasive ductal carcinoma, moderately-differentiated, and intraductal comedo type. Necrosis is present within the intraductal subtype. Lymphovascular invasion is present in lymphatics while calcifications occur in both malignant and benign areas. Surgical margins are free of cancer. One out of fifteen axillary lymph nodes show extensive replacement. No carcinoma is identified on surgical margins, and tumor distance from the closest deep margin is 0.6 cm.

